Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

被引：0

作者：

Julie M. Vose

Kai Fu

Lu Wang

Adnan Mansoor

Douglas Stewart

Hongxia Cheng

Lynette Smith

Ji Yuan

Hina Naushad Qureishi

Brian K. Link

Melissa H. Cessna

Paul M. Barr

Brad S. Kahl

Matthew S. Mckinney

Nadia Khan

Ranjana H. Advani

Peter Martin

Andre H. Goy

Tycel J. Phillips

Amitkumar Mehta

Manali Kamdar

Michael Crump

Barbara Pro

Christopher R. Flowers

Caron A. Jacobson

Sonali M. Smith

Deborah M. Stephens

Veronika Bachanova

Zhaohui Jin

Shishou Wu

Francisco Hernandez-Ilizaliturri

Pallawi Torka

Andrea Anampa-Guzmán

Farshid Kashef

Xing Li

Sunandini Sharma

Timothy C. Greiner

James O. Armitage

Matthew Lunning

Dennis D. Weisenburger

Robert G. Bociek

Javeed Iqbal

Guohua Yu

Chengfeng Bi

机构：

[1] University of Nebraska Medical Center,Division of Oncology and Hematology, Department of Internal Medicine

[2] Nebraska Medicine Fred and Pamela Buffett Cancer Center,Department of Pathology

[3] Roswell Park Comprehensive Cancer Center,Department of Pathology and Microbiology

[4] University of Nebraska Medical Center,School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education

[5] Yantai University,Department of Pathology and Laboratory Medicine

[6] University of Calgary,Departments of Oncology and Medicine

[7] University of Calgary,Department of Pathology

[8] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Biostatistics

[9] University of Nebraska Medical Center,Department of Laboratory Medicine and Pathology

[10] Mayo Clinic,Department of Internal Medicine

[11] University of Iowa Hospitals & Clinics,Department of Medicine

[12] Department of Pathology,Department of Medicine, Oncology Division

[13] Intermountain Medical Center,Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine

[14] University of Rochester Medical Center,Department of Hematology/Oncology, Department of Hematology/Oncology

[15] Washington University School of Medicine in St. Louis,Division of Oncology

[16] Duke University Medical Center,Division of Hematology and Oncology

[17] Fox Chase Cancer Center,Department of Internal Medicine, Division of Hematology/Oncology

[18] Stanford Cancer Institute,O’Neal Comprehensive Cancer Center

[19] Weill Cornell Medical College,Division of Hematology

[20] John Theurer Cancer Center at Hackensack University Medical Center,Division of Medical Oncology and Hematology

[21] University of Michigan Medical School,Division of Hematology and Oncology, Department of Medicine

[22] University of Alabama at Birmingham,Division of Cancer Medicine, Department of Lymphoma

[23] University of Colorado,Myeloma

[24] Princess Margaret Cancer Centre - University Health Network,Department of Medical Oncology, Dana

[25] Northwestern University Feinberg School of Medicine,Farber Cancer Institute

[26] MD Anderson Cancer Center,Section of Hematology/Oncology, Department of Medicine

[27] Harvard Medical School,Division of Hematology, Oncology and Transplantation, Department of Medicine

[28] University of Chicago,Department of Oncology

[29] Huntsman Cancer Institute at University of Utah,Department of Pathology, Affiliated Yantai Yuhuangding Hospital

[30] University of Minnesota,Department of Medicine

[31] Mayo Clinic,Department of Medicine

[32] Qingdao University,Department of Pathology

[33] Roswell Park Comprehensive Cancer Center,undefined

[34] Memorial Sloan Kettering Cancer Center,undefined

[35] University at Buffalo,undefined

来源：

Journal of Hematology & Oncology | / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Identification of a Novel Prognostic microRNA Signature in Mantle Cell Lymphoma
Goswami, R. S.
Afenafu, E. G.
Waldron, L.
Xuan, Y.
Xu, W.
Reis, P. P.
Kuruvilla, J.
Good, D. J.
Bailey, D. J.
Lai, R.
Church, A.
Lam, W. S.
LeBrun, D. P.
Sehn, L. H.
Farinha, P.
Gascoyne, R. D.
Crump, M. R.
Jurisica, I.
Kamel-Reid, S.
MODERN PATHOLOGY, 2012, 25 : 337A - 337A
[22] Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
Jo, Jae-Cheol
Kim, Seok Jin
Lee, Ho Sup
Eom, Hyeon-Seok
Lee, Soon Il
Park, Yong
Lee, Jeong-Ok
Lee, Yoojin
Yhim, Ho-Young
Yang, Deok-Hwan
Byun, Ja Min
Kang, Hye Jin
Kim, Hyo Jung
Shin, Ho-Jin
Yoo, Kwai Han
Suh, Cheolwon
ANNALS OF HEMATOLOGY, 2020, 99 (02) : 223 - 228
[23] Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
Jae-Cheol Jo
Seok Jin Kim
Ho Sup Lee
Hyeon-Seok Eom
Soon Il Lee
Yong Park
Jeong-Ok Lee
Yoojin Lee
Ho-Young Yhim
Deok-Hwan Yang
Ja Min Byun
Hye Jin Kang
Hyo Jung Kim
Ho-Jin Shin
Kwai Han Yoo
Cheolwon Suh
Annals of Hematology, 2020, 99 : 223 - 228
[24] Proteogenomic Features Define Novel Subtypes of Mantle Cell Lymphoma
Yan, Yuting
Ge, Xinzhou
Sun, Jian
Yu, Lei
Zhang, Qunling
Yu, Ying
Jia, Zhenyu
Zou, Dehui
Li, Jessica
Qiu, Lugui
Wang, Lili
Yi, Shuhua
BLOOD, 2023, 142
[25] Mantle cell lymphoma -: Presenting features, response to therapy and prognostic factors
Bosch, F
López-Guillermo, A
Campo, E
Ribera, JM
Conde, E
Piris, MA
Vallespí, T
Woessner, S
Montserrat, E
CANCER, 1998, 82 (03) : 567 - 575
[26] Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
Enjuanes, Anna
Fernandez, Veronica
Hernandez, Luis
Navarro, Alba
Bea, Silvia
Pinyol, Magda
Lopez-Guillermo, Armando
Rosenwald, Andreas
Ott, German
Campo, Elias
Jares, Pedro
PLOS ONE, 2011, 6 (05):
[27] Integrative Analysis of Genetic and Tumor Microenvironment Topology to Delineate Prognostic Subtypes in Mantle Cell Lymphoma
Sharma, Sunandini
Bouska, Alyssa C.
Gamboa, Alicia
Ali, Roshia
Issa, Issa Ismail
Lone, Waseem G.
Jochum, Dylan T.
Zhang, Weiwei
Elhag, Salma
Ghersi, Dario
ElGamal, Dalia
Vose, Julie M.
Bi, Chengfeng
Merchant, Akil
Iqbal, Javeed
BLOOD, 2022, 140 : 3601 - 3602
[28] High-Risk Mantle Cell Lymphoma in the Era of Novel Agents
Nabrinsky, Edward
Danilov, Alexey V.
Koller, Paul B.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (01) : 8 - 18
[29] Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies
Ermann, Daniel A.
Vardell, Victoria A.
Fitzgerald, Lindsey
Shah, Harsh
Bock, Allison M.
Stephens, Deborah M.
Hu, Boyu
BLOOD, 2023, 142
[30] High-Risk Mantle Cell Lymphoma in the Era of Novel Agents
Edward Nabrinsky
Alexey V. Danilov
Paul B. Koller
Current Hematologic Malignancy Reports, 2021, 16 : 8 - 18

← 1 2 3 4 5 →